CAS: 2624-43-3; Cyclofenil,4,4'-(Cyclohexylidenemethylene)Bisphenol1,1'-Diacetate

该化合物是一种具有二苯乙烯结构的非有组织选择性雌激素受体调节器(SERM),视目标组织而定,具有雌性诱变和异性诱变的特性,使其在临床和研究应用中有用.Cyclofenil主要研究其在治疗月经紊乱,不孕症和雌激素不平衡相关条件方面的潜力,其机制涉及对雌激素受体的竞争性约束,调节荷尔蒙活动,而没有内生雌激素的完全反动效应.该化合物与其他SEMM相比,其相对轻微的副作用是已知的.Cyclofenil的稳定性和生物利用率进一步有助于其在药理学研究和治疗发展方面的效用.

结构式图片

欧盟法规

ECHA物质C&L通报REACH预注册

上下游产品

2,2-bis(4-hydroxyphenyl)methylenecyclohexane acetic anhydride 1,1'-(cyclohexylidenemethylene)bis(4-methoxy)benzene 4,4'-Dihydroxybenzophenone2,2-bis(4-hydroxyphenyl)methylenecyclohexane

合成工艺路线路线简述

    📜4,4'-二羟基二苯甲酮置于titanium(III) Chloride,Lithium体系中,用 吡啶,乙二醇二甲醚 用作溶剂,化学反应 17.0H,反应生成环芬尼
    参考文献:低价钛新合成赛庚啶和相关化合物
    标题:低价钛新合成赛庚啶和相关化合物
    摘要:描述了一种基于两种合适的酮与低价钛的不对称二羰基偶联制备联苯亚甲基哌啶,赛庚啶和相关化合物的简单方法.
    Doi:10.1016/s0040-4020(01)89809-4

    海关参考信息

    专利信息


    专利号:US-11873305-B2
    优先权日:2020-06-30
    标题 :Processes for synthesis of substituted indole intermediates for the synthesis of serd compounds
    发明人:ZHANG HAIMING; XU JIE; WUITSCHIK GEORG; ANGELAUD REMY; HEROLD SEBASTIAN; STUTZ ALFRED; BRUETSCH TOBIAS; BURKHARD JOHANNES
    权利人:GENENTECH INC; HOFFMANN LA ROCHE
    摘要:Provided herein are processes for the preparation of indolyl intermediates using Wenker Synthesis for the total synthesis of SERD compounds useful in the treatment of cancer.

    专利号:US-8647823-B2
    优先权日:2005-07-22
    标 题 :Polynucleotide synthesis on a modified surface
    发明人:PARK JOON-WON; HONG BONG-JIN
    权利人:PARK JOON-WON; HONG BONG-JIN; POSTECH FOUNDATION; POSCO
    摘要:The present invention relates to a method for the synthesis of a polynucleotide on a modified surface of a substrate, wherein the modified surface is obtained by chemically modifying with macromolecules in which a plurality of termini of the branched region are bound to the surface and a terminus of the linear region is functionalized.

    专利号:US-9936723-B2
    优先权日:2014-02-12
    标题 :Process for the synthesis of substituted 1-benzyl-3-(1-(isoxazol-4-ylmethyl)-1h-pyrazol-4-yl)imidazolidine-2,4-diones
    发明人:FOTSING JOSEPH R
    权利人:SENOMYX INC
    摘要:The present invention relates to processes and intermediates for the preparation of compounds of formula (I): n nor a salt or oxide thereof, wherein Alk, M1, M2, R1, R2, R3, R4, R5, R6, R7, and n are as described herein. The present invention also relates to compounds of formula (I) and composition comprising a compound of formula (I). Also disclosed is a method of altering or improving the taste of a composition that includes adding to the composition at least one compound of formula (I), in an amount effective to obtain a modified composition having altered or improved taste relative to an otherwise identical composition lacking said compound.

    专利号:US-2025289827-A1
    优先权日:2022-12-02
    标 题:Morphic forms of a mutant braf degrader and methods of manufacture thereof
    发明人:YU ROBERT T; HE MINSHENG; SCHNADERBECK MATTHEW J; KREGER BRIDGET; POLLOCK ROY MACFARLANE; JIANG SIYI; LI MEIQI; CHEN BOLU; LU JIANNAN
    权利人:C4 THERAPEUTICS INC
    摘要:Advantageous isolated morphic forms of (3R)-3-[6-[2-cyano-3-[[ethyl(methyl)sulfamoyl]amino]-6-fluorophenoxy]-4-oxoquinazolin-3-yl]-8-[2-[1-[3-(2,4-dioxo-1,3-diazinan-1-yl)-5-fluoro-1-methylindazol-6-yl]-4-hydroxypiperidin-4-yl]acetyl]-1-oxa-8-azaspiro[4.5]decane (Compound 1), which is a mutant BRAF degrader, and methods to prepare Compound 1 morphic forms for therapeutic applications are provided in the invention. The invention also provides improved methods for the synthesis of Compound 1, new pharmaceutical compositions comprising Compound 1, and new uses of Compound 1.

    专利号:US-2024174678-A1
    优先权日:2020-06-30
    标 题 :Processes for synthesis of substituted indole intermediates for the synthesis of serd compounds

    专利号:EP-3104712-A1
    优先权日:2014-02-12
    标题 :Improved process for the synthesis of substituted 1-benzyl-3-(1-(isoxazol-4-ylmethyl)-1h-pyrazol-4-yl)imidazolidine-2,4-diones

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Thompson LA, Barratt CL, Thornton SJ, Bolton AE, Cooke ID. The effects of clomiphene citrate and cyclofenil on cervical mucus volume and receptivity over the periovulatory period. Fertil Steril. 1993 Jan;59(1):125-9. pii: bcr2012007825. doi: 10.1136/bcr-2012-007825.
    3: Bhathena RK, Patel RH, Varma TR. The effects of Cyclofenil on the Cervical Mucus Score (Insler). Int J Gynaecol Obstet. 1986 Feb;24(1):17-9. doi: 10.1002/jms.1462. doi: 10.1021/ja100248q.
    6: Lancaster CA, Fryer PR, Griffiths S, Mason RM. Ultrastructural changes accompany inhibition of proteoglycan synthesis in chondrocytes by Cyclofenil diphenol. J Cell Sci. 1989 Feb;92 ( Pt 2):271-80. Review. doi: 10.1021/jm100047k.

    合成参考文献


    摘要:Oyo Yakuri. Pharmacometrics., 4(821), 1970
    摘要:Drugs in Japan, 6(313), 1982
    参考文献:10.1111/j.0954-6820.1980.tb09690.x
    摘要:Herbai G, Boczán J. Effect of Cyclofenil Treatment on Arterial Insufficiency Demonstrated in a Patient by Colour Thermography. Journal of Internal Medicine. 1980 Jan 12;207(1-6):127–30. doi: 10.1111/j.0954-6820.1980.tb09690.x.
    摘要:S109 | PARCEDC | List of 7074 potential endocrine disrupting compounds (EDCs) by PARC T4.2 | DOI:10.5281/zenodo.10944198
    摘要:S72 | NTUPHTW | Pharmaceutically Active Substances from National Taiwan University | DOI:10.5281/zenodo.3955664
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知